Antimalarial ligands

Shop By
View as List Grid

3 Items

Set Descending Direction
  1. Amodiaquine
    Cas#: 86-42-0        Compound CID:  2165
    Formula:  C20H22ClN3O        Molecular Weight: 355.86
    IUPAC Name: 4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol
    SMILES: CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O
    InChIKey: OVCDSSHSILBFBN-UHFFFAOYSA-N
    InChI: InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)
    Synonyms: 4-[(7-Chloro-4-quinolinyl)amino]-.alpha.-(diethylamino)-o-cresol | Alphaquine | Amodiaquine (USP/INN) | Amodiaquine [...
  2. Altiratinib, Neurotrophic tyrosine kinase receptor inhibitor
    Cas#: 1345847-93-9        Compound CID:  54576299
    Formula:  C26H21F3N4O4        Molecular Weight: 510.46
    IUPAC Name: 1-N'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
    SMILES: C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F
    InChIKey: GNNDEPIMDAZHRQ-UHFFFAOYSA-N
    InChI: InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)
    Synonyms: NSC784590 | NSC-784590 | DCC-270 | J-690136 | Q27074416 | Altiratinib(DCC-2701) | s6412 | GNNDEPIMDAZHRQ-UHFFFAOYSA-N...
  3. Luteolin, Agonist of TAS2R14;Agonist of TAS2R39
    Cas#: 491-70-3        Compound CID:  5280445
    Formula:  C15H10O6        Molecular Weight: 286.24
    IUPAC Name: 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
    SMILES: C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O
    InChIKey: IQPNAANSBPBGFQ-UHFFFAOYSA-N
    InChI: InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H
    Synonyms: Digitoflavone | Luteolol | 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one
per page

We noticed your location and want to make sure you’re viewing the most relevant version of our site.
Would you like to be redirected to your local region’s page for a smoother experience?